Abstract

Stability of Ertapenem in an Elastomeric Infusion Device

Author(s): Phipps Stephen D, Peacock Gina F, Smith Douglas L

Issue: May/Jun 2011 - Volume 15, Number 3

Page(s): 252-254

Download in electronic PDF format for $75
  • Stability of Ertapenem in an Elastomeric Infusion Device Page 1
  • Stability of Ertapenem in an Elastomeric Infusion Device Page 2
  • Stability of Ertapenem in an Elastomeric Infusion Device Page 3

Abstract

Ertapenem is an intravenous antibiotic that is dosed once daily and is utilized in the home infusion setting for parenteral antibiotic therapy. Thepurpose of this study was to evaluate the stability of ertapenem in an elastomeric infusion device over a one-week period. A stability-indicating high-performance liquid chromatographic method for ertapenem was identified from the literature and evaluated in our laboratory. Under our experimental conditions, the method demonstrated acceptable precision (1.8% relative standard deviation) and linearity (r2 = 0.998). Five 1-g vials of commercial grade ertapenem were reconstituted with 10 mL of sterile water for injection according to the manufacturer’s directions and then transferred into an elastomeric infusion device along with 90 mL of 0.9% sodium chloride solution (concentration of 10 mg/mL). After preparation of the ertapenem solutions, the five elastomeric infusion devices were stored under refrigerated conditions (5oC). Ertapenem concentrations were assayed in duplicate at the time of initial preparation and at subsequent 24-hour intervals throughout the study. Ertapenem concentrations were quantified by interpolation from a standard curve; ertapenem standard curves were generated each day of the study from solutions of known ertapenem concentration that were prepared from ertapenem analytical standard. At the 72-hour time point, ertapenem concentrations from each of the five elastomeric infusion pumps remained greater than 90% of initial concentration. At the 120-hour time point, the overall average ertapenem concentration was 90.4% of initial concentration, but two out of the five concentrations were below 90% of initial concentration. At the end of the 7-day study, the overall average ertapenem concentration was 88.9% of initial concentration and only one concentration was greater than 90% of initial concentration. Based on the results from this study, a beyond-use date of 3 days (72 hours) is conservatively recommended for ertapenem solutions prepared in Homepump ECLIPSE elastomeric infusion devices that are stored under refrigerated conditions.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2011
Pg. 252-254
Sep/Oct 2010
Pg. 436-439
Sep/Oct 2015
Pg. 432-436
Mar/Apr 2011
Pg. 94-100
Author(s): Miron Karen E
May/Jun 2011
Pg. 183-188
Jul/Aug 2016
Pg. 343-346
Jul/Aug 2000
Pg. 281-285
Author(s): Ashworth Lisa D
Nov/Dec 2011
Pg. 515-520
Jan/Feb 2011
Pg. 6-10
Author(s): Williams LaVonn A
Nov/Dec 2000
Pg. 442-443
Author(s): Ashworth Lisa D
Sep/Oct 2000
Pg. 364
Author(s): Ashworth Lisa D
Mar/Apr 2002
Pg. 152-154
May/Jun 2003
Pg. 170-174
Author(s): Meece Jerry
Mar/Apr 2004
Pg. 156-159
Mar/Apr 2013
Pg. 100-110
Nov/Dec 2010
Pg. 450-455
Author(s): Franklin David M
Jul/Aug 2011
Pg. 270-276
Author(s): Kennedy Steve
Mar/Apr 2023
Pg. 169-174
Jul/Aug 2021
Pg. 330-335
Sep/Oct 2017
Pg. 436-439